DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,019,897 | +1.4% | 24,264 | -1.9% | 0.52% | +5.5% |
| Q2 2023 | $5,934,960 | -6.4% | 24,729 | -1.7% | 0.49% | -9.2% |
| Q1 2023 | $6,339,813 | -5.0% | 25,154 | -0.0% | 0.54% | -10.4% |
| Q4 2022 | $6,676,639 | +2.9% | 25,155 | +0.1% | 0.60% | -1.9% |
| Q3 2022 | $6,489,000 | -2.2% | 25,124 | -4.0% | 0.62% | +3.7% |
| Q2 2022 | $6,636,000 | -12.6% | 26,175 | +1.1% | 0.59% | +0.8% |
| Q1 2022 | $7,592,000 | -9.7% | 25,884 | +1.3% | 0.59% | -6.7% |
| Q4 2021 | $8,410,000 | +10.4% | 25,559 | +2.1% | 0.63% | +2.3% |
| Q3 2021 | $7,619,000 | +15.2% | 25,027 | +1.5% | 0.62% | +10.6% |
| Q2 2021 | $6,614,000 | +13.0% | 24,646 | -5.2% | 0.56% | +5.7% |
| Q1 2021 | $5,854,000 | +0.0% | 26,009 | -1.3% | 0.53% | -4.5% |
| Q4 2020 | $5,853,000 | -4.4% | 26,347 | -7.3% | 0.55% | -12.5% |
| Q3 2020 | $6,123,000 | +15.0% | 28,433 | -5.5% | 0.63% | +7.8% |
| Q2 2020 | $5,323,000 | +23.4% | 30,103 | -3.4% | 0.59% | +4.6% |
| Q1 2020 | $4,312,000 | -2.6% | 31,152 | +7.9% | 0.56% | +21.0% |
| Q4 2019 | $4,429,000 | +17.3% | 28,860 | +10.4% | 0.46% | +9.7% |
| Q3 2019 | $3,776,000 | +11.1% | 26,140 | +9.9% | 0.42% | +9.0% |
| Q2 2019 | $3,398,000 | +42.4% | 23,775 | +31.5% | 0.39% | +36.7% |
| Q1 2019 | $2,387,000 | +13.7% | 18,083 | -11.2% | 0.28% | +4.4% |
| Q4 2018 | $2,099,000 | -21.5% | 20,354 | -17.3% | 0.27% | -10.3% |
| Q3 2018 | $2,674,000 | +1.9% | 24,612 | -7.5% | 0.30% | -3.5% |
| Q2 2018 | $2,625,000 | -35.6% | 26,605 | -36.1% | 0.31% | -34.2% |
| Q1 2018 | $4,075,000 | +30.6% | 41,621 | +23.8% | 0.48% | +30.8% |
| Q4 2017 | $3,121,000 | +303.8% | 33,624 | +273.2% | 0.36% | +287.2% |
| Q3 2017 | $773,000 | -31.3% | 9,009 | -25.6% | 0.09% | -45.0% |
| Q4 2015 | $1,125,000 | -7.7% | 12,113 | -15.3% | 0.17% | -11.4% |
| Q3 2015 | $1,219,000 | -0.4% | 14,303 | 0.0% | 0.19% | +4.9% |
| Q2 2015 | $1,224,000 | +2.7% | 14,303 | +1.9% | 0.18% | +5.1% |
| Q1 2015 | $1,192,000 | +19.0% | 14,040 | +20.1% | 0.18% | +19.0% |
| Q4 2014 | $1,002,000 | +4.7% | 11,690 | -7.1% | 0.15% | +0.7% |
| Q3 2014 | $957,000 | -58.6% | 12,588 | -57.1% | 0.15% | -19.3% |
| Q2 2014 | $2,312,000 | +970.4% | 29,364 | +918.9% | 0.18% | +376.3% |
| Q1 2014 | $216,000 | -2.7% | 2,882 | 0.0% | 0.04% | -7.3% |
| Q4 2013 | $222,000 | +8.8% | 2,882 | -2.0% | 0.04% | -4.7% |
| Q3 2013 | $204,000 | – | 2,942 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |